Board Meetings for UNICHEMLAB
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| UNICHEMLAB | Unichem Laboratories Limited | 29 May 2018 | Financial Results/Dividend | To consider and approve the Audited financial results of the Company for the period ended March 31, 2018 and Recommendation of dividend, if any | |
| UNICHEMLAB | Unichem Laboratories Limited | 05 Feb 2018 | Results | To inter-alia consider and approve the consolidated audited results for the quarter and nine months ended December 31, 2017. | |
| UNICHEMLAB | Unichem Laboratories Limited | 08 Jan 2018 | Results/Buyback | The Company had informed the Exchange regarding a Board Meeting scheduled to be held on January 08, 2018 Inter-alia consider and approve the audited financial results for the quarter and nine months ended December 31, 2017. The Company has now informed the Exchange that the Board of Directors shall inter alia consider a proposal to buy back the fully paid up equity shares of the Company.(Purpose Revised) | |
| UNICHEMLAB | Unichem Laboratories Limited | 08 Jan 2018 | Results | Inter-alia consider and approve the audited financial results for the quarter and nine months ended December 31, 2017. | |
| UNICHEMLAB | Unichem Laboratories Limited | 03 Nov 2017 | Results | to interalia consider and approve the Unaudited Financial Statements for the quarter and half year ended September 30, 2017. | |
| UNICHEMLAB | Unichem Laboratories Limited | 31 Oct 2017 | Results | To interalia consider and approve the Unaudited Financial Statements for the quarter and half year ended September 30, 2017. | |
| UNICHEMLAB | Unichem Laboratories Limited | 09 Aug 2017 | Results | To inter alia consider and approve the Unaudited Financial Statements for the first quarter ended June 30, 2017. | |
| UNICHEMLAB | Unichem Laboratories Limited | 30 May 2017 | Results/Dividend | To interalia consider and approve the following matters: a. Audited Financial Results of the Company for the year ended March 31, 2017. b. Recommendation of Final Dividend, if any, for the Financial Year ended March 31, 2017. | |
| UNICHEMLAB | Unichem Laboratories Limited | 21 Jan 2017 | Results | to interalia consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2016. | |
| UNICHEMLAB | Unichem Laboratories Limited | 21 Oct 2016 | Results | To interalia consider and approve the Unaudited Financial Results of the Company for the quarter and six months ended September 30, 2016. Further, in terms of the Company s Code of Conduct to Regulate, Conduct, Monitor and Report Trading by Insiders, formulated and adopted under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in shares of the Company will remain closed for Designated Persons, Insiders and their Immediate Relatives from October 6, 2016 to October 23, 2016 (both days inclusive). | |
| UNICHEMLAB | Unichem Laboratories Limited | 23 Jul 2016 | Results | To interalia consider and approve the Unaudited Financial Statements for the first quarter ended June 30, 2016. | |
| UNICHEMLAB | Unichem Laboratories Limited | 20 May 2016 | Results | To interalia consider and approve audited Financial Statements for the year ended March 31, 2016. | |
| UNICHEMLAB | Unichem Laboratories Limited | 20 May 2016 | Results/Dividend | The Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held May 20, 2016 to interalia consider and approve audited Financial Statements for the year ended March 31, 2016. The Company has now informed the Exchange that the Board will also consider the recommendation of final dividend, if any. ( Purpose Revised). | |
| UNICHEMLAB | Unichem Laboratories Limited | 09 Mar 2016 | Dividend | To interalia consider and approve declaration of Interim Dividend . | |
| UNICHEMLAB | Unichem Laboratories Limited | 23 Jan 2016 | Results | Inter-alia, to consider and approve the Un-Audited Financial Results for the quarter and nine months ended December 31, 2015. |